Work

Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention

Year: 2018

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2018.08.004

Authors: Laura Mauri, Ajay J. Kirtane, Stephan Windecker, Robert W. Yeh, Harold L. Dauerman, Matthew J. Price, Thomas Christen, Dominic J. Allocco, Ian T. Meredith, Dean J. Kereiakes

Institutions: Brigham and Women's Hospital, Harvard University, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Cardiovascular Research Foundation, Columbia University, University Hospital of Bern, Beth Israel Deaconess Medical Center, University of Vermont, Scripps Clinic, Boston Scientific (United States), Christ Hospital

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2886766793

FWCI: 3.586

Cites: 32

Cited by: 25

Related to: 10